Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A 6-week, Double Masked, Placebo-controlled Study to Evaluate the Efficacy and Safety of Twice-daily Brinzolamide 1% / Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to Travoprost 0.
Brief Summary:
The purpose of this study is to determine the incremental intraocular pressure (IOP) lowering that is achieved when brinzolamide 1% / brimonidine 0.2%, BID, is used adjunctively to travoprost in patients with normal tension glaucoma that may benefit from further intraocular pressure lowering.
Data from this study will result in publications and provide health care practitioners with important treatment guidance on the use of brinzolamide 1% / brimonidine 0.2% in this clinical setting.